Two FOXP3+CD4+ T cell subpopulations distinctly control the prognosis of colorectal cancers

Saito, Takuro, Nishikawa, Hiroyoshi, Wada, Hisashi, Nagano, Yuji, Sugiyama, Daisuke, Atarashi, Koji, Maeda, Yuka, Hamaguchi, Masahide +14 more·2016·Nature Medicine

Cited by (874)

Items 301–400 of 874

  1. Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer
    Akinori Sasaki, Yoshiaki Nakamura, Yosuke Togashi, Hirofumi Kuno, Hidehiro Hojo, Shun‐Ichiro Kageyama, Naoki Nakamura, Kenji Takashima, Tomohiro Kadota, Yusuke Yoda et al. · 2020 · Gastric Cancer
  2. Immunoregulatory Cells in Myasthenia Gravis
    Ying Wu, Jie Luo, Oliver A. Garden · 2020 · Frontiers in Neurology
  3. Follistatin-Like 3 Correlates With Lymph Node Metastasis and Serves as a Biomarker of Extracellular Matrix Remodeling in Colorectal Cancer
    Chao Yang, Fengyu Cao, Shuoyang Huang, Yongbin Zheng · 2021 · Frontiers in Immunology
  4. Tumor-Associated Regulatory T Cells in Non-Small-Cell Lung Cancer: Current Advances and Future Perspectives
    Jiaqi Liang, Guoshu Bi, Guangyao Shan, Xing Jin, Yunyi Bian, Qun Wang · 2022 · Journal of Immunology Research
  5. Lipid metabolism in tumor-infiltrating regulatory T cells: perspective to precision immunotherapy
    Yukai Shan, Tian-Ao Xie, Yuchao Sun, Zi-Yi Lu, Win Topatana, Sarun Juengpanich, Tian-Bin Chen, Yina Han, Jiasheng Cao, Jiahao Hu et al. · 2024 · Biomarker Research
  6. The gut microbiota can orchestrate the signaling pathways in colorectal cancer
    Astrid Louise Bjørn Bennedsen, Sara Furbo, Thomas Bjarnsholt, Hans Raskov, Ismail Gögenür, Lasse Kvich · 2022 · Apmis
  7. Different subpopulations of regulatory T cells in human autoimmune disease, transplantation, and tumor immunity
    Zhongyi Jiang, Haitao Zhu, Pusen Wang, Weitao Que, Lin Zhong, Xiao‐Kang Li, Futian Du · 2022 · MedComm
  8. Combining precision oncology and immunotherapy by targeting the MALT1 protease
    Thorsten R. Mempel, Daniel Krappmann · 2022 · Journal for ImmunoTherapy of Cancer
  9. CD30+OX40+ Treg is associated with improved overall survival in colorectal cancer
    Lam, Jian Hang, Hong, Michelle, Koo, Si-Lin, Chua, Clarinda Wei Ling, Lim, Kah Ling, Wee, Felicia, Wan, Wei Keat, Leow, Wei Qiang, Yeo, Joo Guan, Tan, Iain Bee Huat et al. · 2021 · Cancer Immunology, Immunotherapy
  10. RANKL/RANK signaling recruits Tregs via the CCL20–CCR6 pathway and promotes stemness and metastasis in colorectal cancer
    Jing Ouyang, Shuang Hu, Qingqing Zhu, Chenxin Li, Tingting Kang, Wenlin Xie, Yun Wang, Yan Li, Yingsi Lu, Junhua Qi et al. · 2024 · Cell Death and Disease
  11. Strategy to targeting the immune resistance and novel therapy in colorectal cancer
    Gang Wang, Junjie Wang, Rui Guan, Yan Sun, Feng Shi, Jiayan Zhang, Zimeng Li, Jing Gao, Xingli Fu · 2018 · Cancer Medicine
  12. Upregulation of TIGIT and PD-1 in Colorectal Cancer with Mismatch-repair Deficiency
    Xuebing Zhou, Xiaoling Ding, Hai Li, Chun K. Yang, Zhanbing Ma, Guangxian Xu, Shaoqi Yang, Dong Zhang, Xiaoliang Xie, Xin Lei et al. · 2020 · Immunological Investigations
  13. Emerging Trends for Radio-Immunotherapy in Rectal Cancer
    Claudia Corrò, Valérie Dutoit, Thibaud Koessler · 2021 · Cancers
  14. Immunomodulatory Effect of Lactobacillus casei in a Murine Model of Colon Carcinogenesis
    Josefina Casas‐Solís, María del Rosario Huizar-López, César Antonio Irecta-Nájera, María Luisa Pita‐López, Anne Santerre · 2019 · Probiotics and Antimicrobial Proteins
  15. Identification and functional analysis of heterogeneous FOXP3+ Treg cell subpopulations in human pancreatic ductal adenocarcinoma
    Gang Yi, Shiwei Guo, Wenyu Liu, Huan Wang, Rendong Liu, Andy Tsun, Gang Y Jin, Bin Li · 2018 · 中国科学通报:英文版
  16. Transcriptional regulation of Treg homeostasis and functional specification
    Ke Wang, Wenxian Fu · 2020 · Cellular and Molecular Life Sciences
  17. Tumour immune microenvironment biomarkers predicting cytotoxic chemotherapy efficacy in colorectal cancer
    Kate Jessica Wilkinson, Weng Leong Ng, Tara Laurine Roberts, Therese M. Becker, Stephanie Hui-Su Lim, Wei Ming Chua, Cheok Soon Lee · 2021 · Journal of Clinical Pathology
  18. Study on the Immune Escape Mechanism of Acute Myeloid Leukemia With DNMT3A Mutation
    Yimei Que, Huimin Li, Liman Lin, Xiaojian Zhu, Min Xiao, Ying Wang, Li Zhu, Dengju Li · 2021 · Frontiers in Immunology
  19. A Potential Role for Integrin-Linked Kinase in Colorectal Cancer Growth and Progression via Regulating Senescence and Immunity
    Saleh Almasabi, Afsar U. Ahmed, Richard L. Boyd, Bryan R.G. Williams · 2021 · Frontiers in Genetics
  20. Role of CD4+CD25+FOXP3+TRegcells on tumor immunity
    Agustinus Darmadi Hariyanto, Tiara Bunga Mayang Permata, Soehartati Argadikoesoema Gondhowiardjo · 2021 · Immunological Medicine
  21. Regulatory T Cells in Pancreatic Cancer: Of Mice and Men
    Carmen Mota Reyes, Elke Demir, Kaan Çifcibaşı, Rouzanna Istvánffy, Helmut Friess, İhsan Ekin Demir · 2022 · Cancers
  22. IL-6 Levels Correlate with Prognosis and Immunosuppressive Stromal Cells in Patients with Colorectal Cancer
    Tsunenori Yamamoto, Ryouichi Tsunedomi, Masao Nakajima, Nobuaki Suzuki, Shin Yoshida, Shinobu Tomochika, Ming qing Xu, Yuki Nakagami, Hiroto Matsui, Yukio Tokumitsu et al. · 2023 · Annals of Surgical Oncology
  23. Requirement of Treg-intrinsic CTLA4/PKCη signaling pathway for suppressing tumor immunity
    Christophe Pedros, Ann J. Canonigo-Balancio, Kok‐Fai Kong, Amnon Altman · 2017 · JCI Insight
  24. Prognostic Significance of Pre- and Postoperative Lymphocyte Counts in Patients with Gastric Cancer
    Hiroaki Saito, Yusuke Kono, Yuki Murakami, Yuji Shishido, Hirohiko Kuroda, Manabu Yamamoto, Yoji Fukumoto, Tomohiro Osaki, Keigo Ashida, Yoshiyuki Fujiwara · 2018 · Digestive Surgery
  25. An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
    Hongquan Chen, Renxi Lin, Weibin Lin, Qing Chen, Dongjie Ye, Jing Li, Jinan Feng, Wenxiu Cheng, Mingfang Zhang, Yuanlin Qi · 2022 · Scientific Reports
  26. Prognostic role of tumor-infiltrating lymphocytes in gastric cancer: A systematic review and meta-analysis
    Xiaoqing Cao, Yurou Kang, Ping Tai, Pei Zhang, Xin Hui Lin, Fei Xu, Zhenlin Nie, Bangshun He · 2024 · Clinics and Research in Hepatology and Gastroenterology
  27. CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma
    David J. Stahl, Philipp Gödel, Hyatt Balke‐Want, Rahil Gholamipoorfard, Paul Segbers, Luis Tetenborg, Mirjam Koker, Janina Dörr, Lisa Gregor, Daniel Bachurski et al. · 2025 · Cancer Cell
  28. Carboplatin chemoresistance is associated with CD11b+/Ly6C+ myeloid release and upregulation of TIGIT and LAG3/CD160 exhausted T cells
    Doxakis Anestakis, Savvas Petanidis, Kalliopi Domvri, Drosos Tsavlis, Paul Zarogoulidis, Theodora Katopodi · 2019 · Molecular Immunology
  29. Smad7 and Colorectal Carcinogenesis: A Double-Edged Sword
    Edoardo Troncone, Giovanni Monteleone · 2019 · Cancers
  30. Endogenous IL-33 exerts CD8+ T cell antitumor responses overcoming pro-tumor effects by regulatory T cells in a colon carcinoma model
    Yulong Xia, Tatsukuni Ohno, Naoto Nishii, Arundhati Bhingare, Hidetake Tachinami, Yoshihisa Kashima, Shigenori Nagai, Hirohisa Saito, Susumu Nakae, Miyuki Azuma · 2019 · Biochemical and Biophysical Research Communications
  31. Prognostic significance of PD-L1 expression and tumor infiltrating lymphocytes in large cell neuroendocrine carcinoma of lung.
    Yoichi Ohtaki, Kyoichi Kaira, Jun Atsumi, Toshiteru Nagashima, Osamu Kawashima, Takashi Ibe, Mitsuhiro Kamiyoshihara, Ryoichi Onozato, Atsushi Fujita, Tomohiro Yazawa et al. · 2018 · Europe PMC (PubMed Central)
  32. The Tumor Microenvironment and Immunotherapy of Oropharyngeal Squamous Cell Carcinoma
    Marij J.P. Welters, Saskia J A M Santegoets, Sjoerd H. van der Burg · 2020 · Frontiers in Oncology
  33. FOXP3 + regulatory T cells and age‐related diseases
    Biaolong Deng, Weiqi Zhang, Yicheng Zhu, Yangyang Li, Dan Li, Bin Li · 2021 · FEBS Journal
  34. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and in vitro Expanded iTregs
    Zhenzhen Hui, Jiali Zhang, Yu Zheng, Lili Yang, Wenwen Yu, Yang An, Feng Wei, Xiubao Ren · 2021 · Frontiers in Immunology
  35. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells
    Takashi Maruyama, Shuhei Kobayashi, Hiroko Nakatsukasa, Yuki Moritoki, Daiki Taguchi, Yoichi Sunagawa, Tatsuya Morimoto, Atsuko Asao, Wenwen Jin, Yuji Owada et al. · 2021 · Frontiers in Immunology
  36. Intratumoral regulatory T cells from colon cancer patients comprise several activated effector populations
    Louis Szeponik, Filip Ahlmanner, Patrik Sundström, William Carl Ivar Rodin, Bengt G. Gustavsson, Elinor Bexe Lindskog, Yvonne Wettergren, Marianne Quiding‐Järbrink · 2021 · BMC Immunology
  37. Comparison of Tumor Microenvironments Between Primary Tumors and Brain Metastases in Patients With NSCLC
    Daiki Ikarashi, Tamio Okimoto, Takehito Shukuya, Hiroko Onagi, Takuo Hayashi, Sara L. Sinicropi-Yao, Joseph M. Amann, Tetsuya Nakatsura, Shigehisa Kitano, David Paul Carbone · 2021 · JTO Clinical and Research Reports
  38. Clinical and Immunological Effects of p53-Targeting Vaccines
    Shan Zhou, Chunmei Fan, Zhaoyang Zeng, Ken H. Young, Yong Li · 2021 · Frontiers in Cell and Developmental Biology
  39. Pretreatment tumour immune microenvironment predicts clinical response and prognosis of muscle-invasive bladder cancer in the neoadjuvant chemotherapy setting
    Daiki Ikarashi, Shigehisa Kitano, Takashi Tsuyukubo, Kazumasa Takenouchi, Takayuki Nakayama, Hiroko Onagi, Asumi Sakaguchi, Makiko Yamashita, Hidenori Mizugaki, Shigekatsu Maekawa et al. · 2021 · British Journal of Cancer
  40. Mast cells inhibit colorectal cancer development by inducing ER stress through secreting Cystatin C
    Feifei Song, Youhua Zhang, Qi Chen, Dexi Bi, Muqing Yang, Ling Lu, Man Li, Huiyuan Zhu, Ying Liu, Qing Wei et al. · 2022 · Oncogene
  41. The Role of Regulatory T Cells in Cancer Treatment Resistance
    Anna Dąbrowska, Magdalena Grubba, Amar Balihodzic, Olga Szot, Bartosz Kamil Sobocki, Adrian Perdyan · 2023 · International Journal of Molecular Sciences
  42. Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer
    Dhifaf Sarhan, Caroline Leijonhufvud, Shannon M. Murray, Kristina Witt, Christina Seitz, Majken Wallerius, Hanjing Xie, Anders Ullén, Ulrika Harmenberg, Elisabet Kerstin Lidbrink et al. · 2017 · OncoImmunology
  43. On the role of retinoic acid in virus induced inflammatory response in cornea
    Ujjaldeep Jaggi, Siva Karthik Varanasi, Siddheshvar Bhela, Barry T. Rouse · 2018 · Microbes and Infection
  44. Correlation between subsets of tumor-infiltrating immune cells and risk stratification in patients with cervical cancer
    Rui Chen, Yi Gong, Dongling Zou, Lifeng Wang, Li Yuan, Qi Zhou · 2019 · PeerJ
  45. Late-stage MC38 tumours recapitulate features of human colorectal cancer – implications for appropriate timepoint selection in preclinical studies
    Nicholas J. Shields, Estelle M. Peyroux, Angela L. Ferguson, Megan C. Steain, Silke Neumann, Sarah L. Young · 2023 · Frontiers in Immunology
  46. CCL19/CCR7 drives regulatory T cell migration and indicates poor prognosis in gastric cancer
    Danhua Xu, Xu Liu, Shouyu Ke, Yixian Guo, Chunchao Zhu, Hui Cao · 2023 · BMC Cancer
  47. Spatial Dissection of the Immune Landscape of Solid Tumors to Advance Precision Medicine
    Francesco Di Mauro, Giuseppina Arbore · 2024 · Cancer Immunology Research
  48. Spatial Heterogeneity of Intratumoral Microbiota: A New Frontier in Cancer Immunotherapy Resistance
    Qiwen Tan, Xiongjing Cao, Falong Zou, Hanwenchen Wang, Lijuan Xiong, Shenghe Deng · 2025 · Biomedicines
  49. Cancer‐Associated Fibroblasts: Heterogeneity, Cancer Pathogenesis, and Therapeutic Targets
    Yutao Li, Qingyun Liu, Xilin Jing, Yuqi Wang, Xiaohua Jia, Xing Yang, Kezhong Chen · 2025 · MedComm
  50. Regulatory T cells control endothelial chemokine production and migration of T cells into intestinal tumors of APCmin/+ mice
    Paulina Akéus, Louis Szeponik, Filip Ahlmanner, Patrik Sundström, Samuel Alsén, Bengt G. Gustavsson, Tim D. Sparwasser, Sukanya Raghavan, Marianne Quiding‐Järbrink · 2018 · Cancer Immunology Immunotherapy
  51. Single-cell RNA-seq unveils critical regulators of human FOXP3+ regulatory T cell stability
    Yi, Gang, Zhao, Yi, Xie, Feng, Zhu, Fuxiang, Wan, Ziyun, Wang, Jingwan, Wang, Xie, Gao, Kai, Cao, Lixia, Li, Xinyang et al. · 2020 · Science Bulletin
  52. Immunomodulation by Inflammation during Liver and Gastrointestinal Tumorigenesis and Aging
    Nao Nagai, Yotaro Kudo, Daisuke Aki, Hayato Nakagawa, Koji Taniguchi · 2021 · International Journal of Molecular Sciences
  53. The Role of Dectin-1 Signaling in Altering Tumor Immune Microenvironment in the Context of Aging
    Natarajan Bhaskaran, Sangeetha Jayaraman, Cheriese Quigley, Prerna Mamileti, Mahmoud Afif Ghannoum, Aaron Weinberg, Jason E. Thuener, Quintin Pan, Pushpa Pandiyan · 2021 · Frontiers in Oncology
  54. FOXP3-based immune risk model for recurrence prediction in small-cell lung cancer at stages I–III
    Minlin Jiang, Chunyan Wu, Liping Zhang, Chenglong Sun, Hao Wang, Yi Xu, Hui Sun, Jun Zhu, Wencheng Zhao, Qiyu Fang et al. · 2021 · Journal for ImmunoTherapy of Cancer
  55. Tumor SQSTM1 (p62) expression and T cells in colorectal cancer
    Keisuke Kosumi, Yohei Masugi, Juhong Yang, Zhi Rong Qian, Sun A. Kim, Wanwan Li, Yan Xia Shi, Annacarolina da Silva, Tsuyoshi Hamada, Li Liu et al. · 2017 · OncoImmunology
  56. MicroRNA-645 is an oncogenic regulator in colon cancer
    Su Guo, Xiuli Guo, J Wang, C Y Wang, R H Yang, F H Wang, Xuezheng Li, Hubert Hondermarck, Rick Francis Thorne, Yufang Wang et al. · 2017 · Oncogenesis
  57. A Tricin Derivative from Deschampsia antarctica Desv. Inhibits Colorectal Carcinoma Growth and Liver Metastasis through the Induction of a Specific Immune Response
    Mariana Malvicini, Ana Gutiérrez‐Moraga, Marcelo M. Rodríguez, Sofia Gomez-Bustillo, Lorena Salazar, Carlos E. Sunkel, Leonor Nozal, Antonio Salgado, Manuel M. Hidalgo, Pedro Pablo Lopez-Casas et al. · 2018 · Molecular Cancer Therapeutics
  58. Preclinical Evaluation of Recombinant Human IL15 Protein Fused with Albumin Binding Domain on Anti-PD-L1 Immunotherapy Efficiency and Anti-Tumor Immunity in Colon Cancer and Melanoma
    Fei‐Ting Hsu, Yu‐Chang Liu, Chang-Liang Tsai, Po‐Fu Yueh, Chih-Hsien Chang, Keng-Li Lan · 2021 · Cancers
  59. Tumor‐derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer
    Wenjing Shi, Fang Zhang, Xiaozheng Chen, Shuyun Wang, Haiqin Zhang, Zijiang Yang, Guiying Wang, Yan Zheng, Yali Han, Yuping Sun et al. · 2022 · Cancer Science
  60. High-Dimensional Mass Cytometric Analysis Reveals an Increase in Effector Regulatory T Cells as a Distinguishing Feature of Colorectal Tumors
    Samuel E Norton, Kirsten A. Ward‐Hartstonge, John L McCall, Julia K. H. Leman, Edward S Taylor, Fran M. Munro, Michael A. Black, Barbara Fazekas de St Groth, Helen Marie McGuire, Roslyn A. Kemp · 2019 · The Journal of Immunology
  61. Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future
    Yi Huang, Zili Gu, Yang Fan, Guangxi Zhai, Xiaogang Zhao, Qifeng Sun, Yanbin Shi, Guimei Lin · 2019 · Purinergic Signalling
  62. Human leukocyte antigen class II-based immune risk model for recurrence evaluation in stage I–III small cell lung cancer
    Peixin Chen, Lishu Zhao, Hao Wang, Liping Zhang, Wei Zhang, Jun Zhu, Jia Yu, Sha Zhao, Wei Li, Chenglong Sun et al. · 2021 · Journal for ImmunoTherapy of Cancer
  63. Estrogen inhibits the growth of colon cancer in mice through reversing extracellular vesicle-mediated immunosuppressive tumor microenvironment
    Lingling Jiang, Haiyi Fei, Anran Yang, Jiajuan Zhu, Jindan Sun, Xiu Liu, Wenzhi Xu, Jianhua Yang, Songying Zhang · 2021 · Cancer Letters
  64. Intratumoral density of regulatory T cells is a predictor of host immune response and chemotherapy response in colorectal cancer.
    2022 · PubMed Central
  65. Contribution of MMP14-expressing cancer-associated fibroblasts in the tumor immune microenvironment to progression of colorectal cancer
    Yusuke Makutani, Hisato Kawakami, Takahiro Tsujikawa, Kanako Yoshimura, Yasutaka Chiba, Akihiko Ito, Junichiro Kawamura, Koji Haratani, Kazuhiko Nakagawa · 2022 · Frontiers in Oncology
  66. Significance of regulatory T cells in cancer immunology and immunotherapy
    Daisuke Sugiyama, Kunihiko Hinohara, Hiroyoshi Nishikawa · 2022 · Experimental Dermatology
  67. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
    Anja L Frei, Anthony McGuigan, Ritik RAK Sinha, Faiz Jabbar, Luciana Gneo, Tijana Tomasevic, Andrea Harkin, Timothy J. Iveson, Mark P. Saunders, Karin A. Oien et al. · 2024 · The Lancet Oncology
  68. Inhibition of tumor growth by cancer vaccine combined with metronomic chemotherapy and anti-PD-1 in a pre-clinical setting
    Annacarmen Petrizzo, Angela Mauriello, Antonio Luciano, Domenica Rea, Antônio Barbieri, Claudio Arra, Piera Maiolino, Maria Lina Tornesello, Vincenzo Gigantino, Gerardo Botti et al. · 2017 · Oncotarget
  69. HLA class II expression on tumor cells and low numbers of tumor‐associated macrophages predict clinical outcome in oropharyngeal cancer
    Bianca Cioni, Ekaterina S. Jordanova, Erik Hooijberg, Rianne van der Linden, Renée X. de Menezes, Katherine Tan, Stefan M. Willems, Joris B.W. Elbers, Annegien Broeks, Andries Marinus Bergman et al. · 2018 · Head & Neck
  70. Role of heterogeneous regulatory T cells in the tumor microenvironment
    Ting Wei, Weijie Zhong, Qingshan Li · 2020 · Pharmacological Research
  71. Effector memory–type regulatory T cells display phenotypic and functional instability
    Désirée J. Wendering, Leila Amini, Stephan Schlickeiser, Martí Farrera-Sal, Sarah Schulenberg, Lena Peter, Marco Mai, Tino Vollmer, Weijie Du, Maik Stein et al. · 2024 · Science Advances
  72. CD38-mediated metabolic reprogramming promotes the stability and suppressive function of regulatory T cells in tumor
    Ishita Sarkar, Debashree Basak, Puspendu Ghosh, Anupam Gautam, Arpita Bhoumik, Praveen Singh, Anwesha Kar, Shaun Mahanti, Snehanshu Chowdhury, Lagnajita Chakraborty et al. · 2025 · Science Advances
  73. Natural Killer T-Cell Agonist α-Galactosylceramide and PD-1 Blockade Synergize to Reduce Tumor Development in a Preclinical Model of Colon Cancer
    Ying Wang, Madhura Satish Bhave, Hideo Yagita∥, Susanna Cardell · 2020 · Frontiers in Immunology
  74. Pregnancy and Tumour: The Parallels and Differences in Regulatory T Cells
    Prerana Muralidhara, Vanshika Sood, Vishnu Vinayak Ashok, Kushagra Bansal · 2022 · Frontiers in Immunology
  75. Immune Microenvironment in Sporadic Early-Onset versus Average-Onset Colorectal Cancer
    Fanny Andric, Ala Al-Fairouzi, Yvonne Wettergren, Louis Szeponik, Elinor Bexe Lindskog, James C. Cusack, Gerald Tumusiime, Marianne Quiding‐Järbrink, David Ljungman · 2023 · Cancers
  76. A prognostic index for colorectal cancer based on preoperative absolute lymphocyte, monocyte, and neutrophil counts
    Akimitsu Tanio, Hiroaki Saito, Chihiro Uejima, Seigo Takaya, Manabu Yamamoto, Naruo Tokuyasu, Teruhisa Sakamoto, Soichiro Honjo, Keigo Ashida, Yoshiyuki Fujiwara · 2018 · Surgery Today
  77. Computational Image Analysis of T-Cell Infiltrates in Resectable Gastric Cancer: Association with Survival and Molecular Subtypes
    Benjamin R. Challoner, Katharina von Loga, Andrew Woolston, Beatrice L. Griffiths, Nanna Sivamanoharan, Maria Semiannikova, Alice Newey, Louise J. Barber, David Mansfield, Lindsay C. Hewitt et al. · 2020 · JNCI Journal of the National Cancer Institute
  78. HPK1 Influences Regulatory T Cell Functions
    Sansana Sawasdikosol, Renyuan Zha, Timothy S. Fisher, Saba Alzabin, Steven J. Burakoff · 2020 · ImmunoHorizons
  79. Intestinal Regulatory T Cells
    Vanessa Ribeiro Figliuolo, Deepa Rana Jamwal, Pawel R. Kiela · 2021 · Advances in experimental medicine and biology
  80. Microbiome in drug resistance to colon cancer
    Kavita Rajesh Pandey, Shahid Umar · 2021 · Current Opinion in Physiology
  81. Lipidomic Typing of Colorectal Cancer Tissue Containing Tumour-Infiltrating Lymphocytes by MALDI Mass Spectrometry Imaging
    Vanna Denti, Allia Mahajneh, Giulia Capitoli, Francesca Clerici, Isabella Piga, Lisa Pagani, Clizia Chinello, Maddalena M. Bolognesi, Giuseppe Paglia, Stefania Galimberti et al. · 2021 · Metabolites
  82. Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populations
    Xanthi Stachtea, Maurice Bernard Loughrey, Manuela Salvucci, Andreas Ulrich Lindner, Sanghee Cho, Elizabeth McDonough, Anup Sood, John F. Graf, Alberto Santamaría-Pang, Alex D. Corwin et al. · 2021 · Modern Pathology
  83. A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer
    Brouwer, Thomas, Ijsselsteijn, Marieke, Oosting, Jan, Ruano, Dina, van der Ploeg, Manon, Dijk, Frederike, Bonsing, Bert, Fariña, Arantza, Morreau, Hans, Vahrmeijer, Alexander et al. · 2022 · Cancers
  84. Colorectal Cancer and Purinergic Signalling: An Overview
    Gabriela Gonçalves Roliano, Juliana H. Azambuja, Veronica Brunetto, Hannah E. Butterfield, Antônio Nocchi Kalil, Elizandra Braganhol · 2022 · Cancers
  85. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines
    Mitsuru Kinoshita, Shogo Kobayashi, Kunihito Gotoh, Masahiko Kubo, Kôji Hayashi, Yoshifumi Iwagami, Daisaku Yamada, Hirofumi Akita, Takehiro Noda, Tadafumi Asaoka et al. · 2019 · Digestive Diseases and Sciences
  86. The Adaptive and Innate Immune Cell Landscape of Uterine Leiomyosarcomas
    Marco Manzoni, Maddalena M. Bolognesi, Asier Antoranz, Rosanna Mancari, Silvestro Giuliano Carinelli, Mario Faretta, Francesca Maria Bosisio, Giorgio Cattoretti · 2020 · Scientific Reports
  87. Adiponectin-expressing Treg facilitate T lymphocyte development in thymic nurse cell complexes
    Yiwei Zhang, Handi Cao, Jie Chen, Yuanxin Li, Aimin Xu, Yu Wang · 2021 · Communications Biology
  88. Lineage Reprogramming of Effector Regulatory T Cells in Cancer
    Michael L. Dixon, Jonathan D. Leavenworth, Jianmei W. Leavenworth · 2021 · Frontiers in Immunology
  89. Association between effector-type regulatory T cells and immune checkpoint expression on CD8+ T cells in malignant ascites from epithelial ovarian cancer
    Sho Sato, Hirokazu Matsushita, Daisuke Shintani, Yukari Kobayashi, Nao Fujieda, Akira Yabuno, Tadaaki Nishikawa, Keiichi Fujiwara, Kazuhiro Kakimi, Kosei Hasegawa · 2022 · BMC Cancer
  90. Immunoscore Combining CD8, FoxP3, and CD68-Positive Cells Density and Distribution Predicts the Prognosis of Head and Neck Cancer Patients
    Sonia Furgiuele, Géraldine Descamps, Jerome Rene Lechien, Didier Dequanter, Fabrice Journé, Sven Saussez · 2022 · Cells
  91. Regulatory T-cells-related signature for identifying a prognostic subtype of hepatocellular carcinoma with an exhausted tumor microenvironment
    Gen-Hao Zhang · 2022 · Frontiers in Immunology
  92. Tumor-infiltrating lymphocyte: features and prognosis of lymphocytes infiltration on colorectal cancer
    Miao Qin, Gang Chen, Jinxia Hou, Li Wang, Qunfeng Wang, Lina Wang, Dan Jiang, Ye Hu, Bei Xie, Jing Chen et al. · 2022 · Bioengineered
  93. Loss of Y in regulatory T lymphocytes in the tumor micro-environment of primary colorectal cancers and liver metastases
    Magdalena Wójcik, Ulana Juhas, Elyas Mohammadi, Jonas Mattisson, Kinga Drężek-Chyła, Edyta Rychlicka-Buniowska, Bożena Bruhn‐Olszewska, Hanna Davies, Katarzyna Chojnowska, Paweł Olszewski et al. · 2024 · Scientific Reports
  94. Emerging roles of a chemoattractant receptor GPR15 and ligands in pathophysiology
    Yukari Okamoto, Sojin Shikano · 2023 · Frontiers in Immunology
  95. Tumor-Infiltrating Immune Cells in Colorectal Cancer
    Sonia A M Ferkel, Elizabeth A. Holman, Raoul S. Sojwal, Samuel J. S. Rubin, Stephan Rogalla · 2024 · Neoplasia
  96. MicroRNA-96-5p promotes proliferation, invasion and EMT of oral carcinoma cells by directly targeting FOXF2
    Haiyan Wang, Ning Ma, Wenyue Li, Zuomin Wang · 2020 · Biology Open · Retracted
  97. Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma
    Chuan Zhang, Dan Dang, Chenlu Liu, Yuqian Wang, Xianling Cong · 2021 · Journal of Cancer
  98. Emerging Complexity in CD4+T Lineage Programming and Its Implications in Colorectal Cancer
    Daniel Francis Ditoro, Rajatava Basu · 2021 · Frontiers in Immunology
  99. The crosstalk of the human microbiome in breast and colon cancer: A metabolomics analysis
    Anirban Goutam Mukherjee, Uddesh Ramesh Wanjari, Pragya Bradu, Reshma Murali, Sandra Kannampuzha, Tamizhini Loganathan, C. George Priya Doss, Arun Prakash B.P, Kaviyarasi Renu, Abhijit Dey et al. · 2022 · Critical Reviews in Oncology/Hematology
  100. Presence of regulatory T-cells in endometrial cancer predicts poorer overall survival and promotes progression of tumor cells
    Thomas Kolben, Mareike Mannewitz, Carolin Perleberg, Konstantin Schnell, David Anz, Laura Hahn, Sarah Meister, Elisa Schmoeckel, Alexander Burges, Bastian Czogalla et al. · 2022 · Cellular Oncology